
Opinion|Videos|March 28, 2025
IL-17 Inhibitor Treatment Impact on Quality of Life in Psoriasis and Psoriatic Arthritis
Panelists discuss how inhibition of IL-17 in psoriasis treatment significantly improves quality of life by reducing inflammation, skin lesions, itching, and pain. Patients report better psychological well-being, increased social confidence, and improved daily functioning as inflammatory pathways are interrupted.
Advertisement
Episodes in this series

Video content above is prompted by the following:
How does treatment of psoriasis with an IL-17 inhibitor impact patient quality of life?
Advertisement
Advertisement
Advertisement
Trending on Dermatology Times
1
AbbVie Completes $10.9 Billion Apogee Acquisition, Adds Zumilokibart to AD Pipeline
2
Uncovering the Autoimmune Links & Systemic Impact of Chronic Spontaneous Urticaria
3
10 Skin Cancer Exam Tips
4
Dermatology Times Conferences & Meetings Calendar: September 2026
5







